Approved Symbol |
Approved Name |
Location |
Source |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
CCKAR |
cholecystokinin A receptor |
4 |
Mapped by CNV |
PHKG2 |
phosphorylase kinase, gamma 2 (testis) |
16p11.2 |
Mapped by CNV |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
4q26 |
Mapped by CNV |
PLCB2 |
phospholipase C, beta 2 |
15q15 |
Mapped by PBA pathway |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
22q13.1 |
Mapped by CNV |
PLCE1 |
phospholipase C, epsilon 1 |
10q23 |
Mapped by PBA pathway |
PLCD1 |
phospholipase C, delta 1 |
3p22-p21.3 |
Mapped by PBA pathway |
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit |
Xp11.23 |
Mapped by LD-proxy; Mapped by PBA pathway; Mapped by literature SNP |
P2RX6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
22q11.21 |
Mapped by CNV |
PPP3R2 |
protein phosphatase 3, regulatory subunit B, beta |
9q31 |
Mapped by significant region |
ADORA2A |
adenosine A2a receptor |
22q11.23 |
Mapped by CNV |
PLN |
phospholamban |
6q22.1 |
Mapped by significant region |
RYR1 |
ryanodine receptor 1 (skeletal) |
19q13.1 |
Mapped by PBA pathway |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
11q13 |
Mapped by significant region |
EDNRA |
endothelin receptor type A |
4 |
Mapped by PBA pathway |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
Mapped by significant region |
ADCY4 |
adenylate cyclase 4 |
14q11.2 |
Mapped by significant region |
PLCD4 |
phospholipase C, delta 4 |
2q35 |
Mapped by significant region |
LTB4R2 |
leukotriene B4 receptor 2 |
14q11.2-q12 |
Mapped by significant region |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3p26.1 |
Mapped by CNV |
TRPC1 |
transient receptor potential cation channel, subfamily C, member 1 |
3q23 |
Mapped by PBA pathway |
TACR3 |
tachykinin receptor 3 |
4q25 |
Mapped by CNV |
CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
Mapped by PBA pathway |
CACNA1A |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
19p13 |
Mapped by PBA pathway |
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
12p11.23 |
Mapped by LD-proxy; Mapped by literature SNP |
BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
Mapped by PBA pathway |
CCKBR |
cholecystokinin B receptor |
11p15.4 |
Mapped by CNV; Mapped by PBA pathway |
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
17q22 |
Mapped by PBA pathway |
CHRM3 |
cholinergic receptor, muscarinic 3 |
1q41-q44 |
Mapped by CNV; Mapped by PBA pathway |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
Mapped by PBA pathway |
CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
Mapped by CNV; Mapped by PBA pathway |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
17q11.2-q12 |
Mapped by LD-proxy |
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
Mapped by PBA pathway |
CACNA1H |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
16p13.3 |
Mapped by PBA pathway |
RYR3 |
ryanodine receptor 3 |
15q14-q15 |
Mapped by CNV; Mapped by PBA pathway |
RYR2 |
ryanodine receptor 2 (cardiac) |
1q43 |
Mapped by CNV; Mapped by PBA pathway |
CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
Mapped by PBA pathway; Mapped by significant region |
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25-q31 |
Mapped by PBA pathway; Mapped by significant region |
P2RX3 |
purinergic receptor P2X, ligand-gated ion channel, 3 |
11q12 |
Mapped by significant region |